The efficacy of palonosetron for the prevention of postoperative nausea and vomiting : a randomized double-blinded, placebo-controlled trial.
Phase of Trial: Phase III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Palonosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 22 Oct 2013 Primary endpoint has been met as result published in the British Journal of Anaesthesia.
- 27 Sep 2012 New trial record